Fundamental Data for SPNC

SPECTRANET(NSDQ:SPNC)

Spectranetics Corp. is a medical device company engaged in the development, manufacturing, marketing and distribution of its technology for interventional cardiovascular therapy. The Company''s CVX-300 excimer laser system is the only excimer laser system approved by the FDA for multiple cardiovascular procedures. The technology has been designed for use in multiple cardiovascular applications, including coronary angioplasty and the removal of pacemaker and ICD leads. (press release)

# Employees: 427

Address: 9965 Federal Drive,Colorado Springs,CO,USA

Phone: 719 633-8333

Fax: 719-633-2248

Website: www.spectranetics.com

Email:

Sector: Computer and Technology

Industry: LASERS-SYS/COMP

Executive Officers

Emile J. Geisenheimer (Chmn.; Dir.)

John G. Schulte (Presi.; C.E.O.; Dir.)

Guy A. Childs (V.P.; C.F.O.; Prin. Acctg. Off.)

David G. Blackburn (Dir.)

John R. Fletcher (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/18/2010

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): ($0.24)

Mean Estimate(Long Term): $45.00

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 8

Shares Performance

Period	SPNC	Compare to S&P
YTD	130.27 %	90.57 %
4 Weeks	-0.99 %	-2.06 %
12 Weeks	1.52 %	-4.29 %

Shares Information

Analyst Coverage: Y

Avg Volume: 94105

Shares Outstanding: 32M

Market Cap: $0.20B

52 Week High: $6.83

52 Week Low: $2.11

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 SPNC split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 133.33 %

EPS Growth in Last Year: 100.00 %

Sales Growth in Last Quarter: -0.66 %

Sales Growth in Last Quarter: 7.47 %

Financials

Qtr Book Value: $2.23

Cash Flow/Share: $33.01

Change in Payout Ratio: -0.010

Price/Sales: 1.750